Breast Cancer Clinical Trial

- The folks at Hoffmann-La Roche are studying Breast Cancer in individuals ages 18 years and older. This clinical trial is slated to start November 2013 and is expected to end circa September 2018.

888-662-6728 (U.S. Only)
Reference Study ID Number: ML28759 www.roche.com/about_roche/roche_worldwide.htm
Overall Study Contact Info
StatusName Contact Phone
RecruitingReference Study ID Number: ML28759 www.roche.com/about_roche/roche_worldwide.htmglobal.rochegenentechtrials@roche.com888-662-6728 (U.S. Only)

This study is officially titled, "CLINICAL PRACTICE SURVEILLANCE OF THE USE OF HERCEPTIN SUBCUTANEOUS IN PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER (HerSCin)."

Locations

Mainz, Germany - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.